Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies

Objective:. To clarify the surgical outcomes of esophagectomy in Japan and comprehensively evaluate trends over time. It is important to analyze data from a large number of consecutive patients from a single institution. Methods:. We evaluated the treatment outcomes, complications, and prognosis of...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasue Kimura, MD, PhD, Eiji Oki, MD, PhD, Tomonori Nakanoko, MD, PhD, Qingjiang Hu, MD, PhD, Keita Natsugoe, MD, Sho Nanbara, MD, PhD, Ryota Nakanishi, MD, PhD, Yuichiro Nakashima, MD, PhD, Mitsuhiko Ota, MD, PhD, Tomoharu Yoshizumi, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-12-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000347
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589682154668032
author Yasue Kimura, MD, PhD
Eiji Oki, MD, PhD
Tomonori Nakanoko, MD, PhD
Qingjiang Hu, MD, PhD
Keita Natsugoe, MD
Sho Nanbara, MD, PhD
Ryota Nakanishi, MD, PhD
Yuichiro Nakashima, MD, PhD
Mitsuhiko Ota, MD, PhD
Tomoharu Yoshizumi, MD, PhD
author_facet Yasue Kimura, MD, PhD
Eiji Oki, MD, PhD
Tomonori Nakanoko, MD, PhD
Qingjiang Hu, MD, PhD
Keita Natsugoe, MD
Sho Nanbara, MD, PhD
Ryota Nakanishi, MD, PhD
Yuichiro Nakashima, MD, PhD
Mitsuhiko Ota, MD, PhD
Tomoharu Yoshizumi, MD, PhD
author_sort Yasue Kimura, MD, PhD
collection DOAJ
description Objective:. To clarify the surgical outcomes of esophagectomy in Japan and comprehensively evaluate trends over time. It is important to analyze data from a large number of consecutive patients from a single institution. Methods:. We evaluated the treatment outcomes, complications, and prognosis of 1500 consecutive patients who underwent esophagectomy during 5 periods: group A (n = 284), 1964–1984; group B (n = 345), 1985–1993; group C (n = 253), 1994–2002; group D (n = 297), 2003–2012; and group E (n = 321), 2013–March 2020. Results:. The incidences of squamous cell carcinoma and adenocarcinoma were 93.8% and 3.3%, respectively. The proportion of adenocarcinoma cases has gradually increased over time. The in-hospital mortality rates for groups A, B, C, D, and E were 12%, 4.6%, 1.2%, 2.9%, and 1.5%, respectively. Group A had a significantly higher mortality rate than the other groups (P < 0.0001). Three-year survival rates were 22.2%, 47.8%, 53.4%, 69.9%, and 72.6% in groups A–E, respectively, 5-year survival rates were 17.2%, 41.3%, 49.2%, 63.9%, and 68.4%, respectively (P < 0.0001, group A vs groups D and E). The prognosis improved over time. Multivariate analysis revealed that depth of invasion, lymph node metastasis, the extent of lymph node resection, curative resection, pulmonary complications, and anastomotic leakage were significant independent prognostic factors. However, for recent surgeries (groups D and E), only the depth of invasion, lymph node metastasis, and curative resection were significant independent prognostic factors. Conclusions:. Valuable changes in background and prognostic factors occurred over time. These findings will help optimize esophageal cancer management and improve patient outcomes.
format Article
id doaj-art-1c33e463962a4b0daa50d3ea8723f39a
institution Kabale University
issn 2691-3593
language English
publishDate 2023-12-01
publisher Wolters Kluwer Health
record_format Article
series Annals of Surgery Open
spelling doaj-art-1c33e463962a4b0daa50d3ea8723f39a2025-01-24T09:18:12ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932023-12-0144e34710.1097/AS9.0000000000000347202312000-00008Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive EsophagostomiesYasue Kimura, MD, PhD0Eiji Oki, MD, PhD1Tomonori Nakanoko, MD, PhD2Qingjiang Hu, MD, PhD3Keita Natsugoe, MD4Sho Nanbara, MD, PhD5Ryota Nakanishi, MD, PhD6Yuichiro Nakashima, MD, PhD7Mitsuhiko Ota, MD, PhD8Tomoharu Yoshizumi, MD, PhD9From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.Objective:. To clarify the surgical outcomes of esophagectomy in Japan and comprehensively evaluate trends over time. It is important to analyze data from a large number of consecutive patients from a single institution. Methods:. We evaluated the treatment outcomes, complications, and prognosis of 1500 consecutive patients who underwent esophagectomy during 5 periods: group A (n = 284), 1964–1984; group B (n = 345), 1985–1993; group C (n = 253), 1994–2002; group D (n = 297), 2003–2012; and group E (n = 321), 2013–March 2020. Results:. The incidences of squamous cell carcinoma and adenocarcinoma were 93.8% and 3.3%, respectively. The proportion of adenocarcinoma cases has gradually increased over time. The in-hospital mortality rates for groups A, B, C, D, and E were 12%, 4.6%, 1.2%, 2.9%, and 1.5%, respectively. Group A had a significantly higher mortality rate than the other groups (P < 0.0001). Three-year survival rates were 22.2%, 47.8%, 53.4%, 69.9%, and 72.6% in groups A–E, respectively, 5-year survival rates were 17.2%, 41.3%, 49.2%, 63.9%, and 68.4%, respectively (P < 0.0001, group A vs groups D and E). The prognosis improved over time. Multivariate analysis revealed that depth of invasion, lymph node metastasis, the extent of lymph node resection, curative resection, pulmonary complications, and anastomotic leakage were significant independent prognostic factors. However, for recent surgeries (groups D and E), only the depth of invasion, lymph node metastasis, and curative resection were significant independent prognostic factors. Conclusions:. Valuable changes in background and prognostic factors occurred over time. These findings will help optimize esophageal cancer management and improve patient outcomes.http://journals.lww.com/10.1097/AS9.0000000000000347
spellingShingle Yasue Kimura, MD, PhD
Eiji Oki, MD, PhD
Tomonori Nakanoko, MD, PhD
Qingjiang Hu, MD, PhD
Keita Natsugoe, MD
Sho Nanbara, MD, PhD
Ryota Nakanishi, MD, PhD
Yuichiro Nakashima, MD, PhD
Mitsuhiko Ota, MD, PhD
Tomoharu Yoshizumi, MD, PhD
Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
Annals of Surgery Open
title Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
title_full Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
title_fullStr Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
title_full_unstemmed Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
title_short Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
title_sort evolution of treatment outcomes and prognostic factors in esophageal cancer surgery a retrospective analysis of 1500 consecutive esophagostomies
url http://journals.lww.com/10.1097/AS9.0000000000000347
work_keys_str_mv AT yasuekimuramdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT eijiokimdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT tomonorinakanokomdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT qingjianghumdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT keitanatsugoemd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT shonanbaramdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT ryotanakanishimdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT yuichironakashimamdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT mitsuhikootamdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies
AT tomoharuyoshizumimdphd evolutionoftreatmentoutcomesandprognosticfactorsinesophagealcancersurgeryaretrospectiveanalysisof1500consecutiveesophagostomies